The effect of intravesical gemcitabine on prevention of recurrence in non-muscle-invasive bladder cancer
Phase 3
- Conditions
- Bladder tumor.Malignant neoplasm of bladder
- Registration Number
- IRCT20220207053961N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 134
Inclusion Criteria
Patients with non-muscle-invasive bladder cancer
Patients candidate of trans urethral resection of tumor (TURT)
Tumor size less than or equal to 3 cm
Low grade tumor on cystoscopy
Diagnosed tumors in first time
Exclusion Criteria
Frequent recurrence
Tumor size above 3 cm
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor size. Timepoint: Three and six months after surgery. Method of measurement: In millimeters on sonography.;Tumor recurrence. Timepoint: Three and six months after surgery. Method of measurement: Having a recurrence based on sonography.
- Secondary Outcome Measures
Name Time Method Tumor site. Timepoint: Three and six months after surgery. Method of measurement: Sonography.